Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Retrorsine selectively inhibits hepatocyte proliferation and following liver injury evokes small hepatocyte-like progenitor cells. Retrorsine can be used for the research of hepatocellular injury.
Description | Retrorsine selectively inhibits hepatocyte proliferation and following liver injury evokes small hepatocyte-like progenitor cells. Retrorsine can be used for the research of hepatocellular injury. |
Targets&IC50 | OCT1:2.2 μM |
In vitro | Retrorsine inhibited the OCT1-mediated 1-methyl-4-phenylpyridinium (MPP(+)) uptake in MDCK-hOCT1 cells with the IC50 of 2.25±0.30μM[1]. Retrorsine (60 μM, 120 μM , 240 μM; 24 h) significantly reduced HSEC-CYP3A4 cell viability and GSH levels and increases the formation of pyrrole-protein adducts[2]. |
In vivo | In male Wistar rats, Retrorsine (30 mg/kg; i.p.; twice) impaired liver regeneration in the PBL model not only by an S or G2/M phase block but also by a block located before the G1/S transition of the cell cycle[3]. |
Molecular Weight | 351.39 |
Formula | C18H25NO6 |
CAS No. | 480-54-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 95 mg/mL (270.35 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Retrorsine 480-54-6 代谢 离子通道 OCT P450 pyrrolizidine inhibit hepatotoxic hepatocellular Inhibitor injury alkaloid inhibitor